BIOMARKERS FOR DIAGNOSING AND DETECTING THE PROGRESSION OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF AMYOTROPHIC LATERAL SCLEROSIS
摘要
<p>The present invention relates to biomarkers, to their use and to a method for detecting the progression of a neurodegenerative disease in an individual, in particular for Amyotrophic Lateral Sclerosis (ALS). The method comprises the steps of quantifying the level of one or more polypeptides in the biological sample according to the invention; comparing the obtained level with a reference level.</p>
